CPAH CounterPath Corporation

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Karp David	2. Issuer Name and Ticker or Trading Symbol COUNTERPATH CORP [ CPAH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Financial Officer
(Last)          (First)          (Middle) 3780 BAYRIDGE AVENUE	3. Date of Earliest Transaction (MM/DD/YYYY) 9/4/2019
(Street) VANCOUVER, A1 V7V 3J2 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares								30973.1164	D
Common Shares	9/4/2019		A		134.4809 (2)	A	$1.4872 (3)	31107.5973	D
Common Shares	9/4/2019		A		63.9467 (2)	A	$1.5638 (3)	31171.544	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$13.10							6/12/2014 (1)	12/12/2018	Common shares	20000		20000	D
Stock Options	$2.40							7/14/2016 (1)	7/14/2021	Common	20000		40000	D
Stock Options	$2.89							12/14/2017 (1)	12/14/2022	Common	50000		90000	D
Deferred Share Units	(4)							12/14/2009	(4)	Common	8065.5 (4)		8064.5	D
Deferred Share Units	(4)							6/18/2010	(4)	Common	5000 (4)		13064.5	D
Deferred Share Units	(4)							3/10/2011	(4)	Common	2202.6 (4)		15267.1	D
Deferred Share Units	(4)							7/25/2011	(4)	Common	5405.4 (4)		20672.5	D
Deferred Share Units	(4)							7/19/2012	(4)	Common	1710.8 (4)		22383.3	D
Deferred Share Units	(4)							7/25/2013 (5)	(4)	Common	2513.9 (4)		24897.2	D
Deferred Share Units	(4)							7/11/2014 (5)	(4)	Common	6048.4 (4)		30945.6	D
Deferred Share Units	(4)							7/17/2015 (5)	(4)	Common	7970.4 (4)		38916.0	D
Deferred Share Units	(4)							7/14/2016	(4)	Common	8076.0		46992.0	D
Deferred Share Units	(4)							7/14/2017	(4)	Common	13376		60368	D
Deferred Share Units	(4)							7/26/2018	(4)	Common	22830.0		83198.0	D
Deferred Share Units	(4)							12/14/2018	(4)	Common	40000		123198	D

Explanation of Responses:
(1)	Options vest as to 12.5% after 6 months and 1/42 per month thereafter as per company plan.
(2)	These shares were purchased through an Employee Share Purchase Plan.
(3)	Canadian dollars.
(4)	Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. Deferred share units vest as to one-third of the number granted on each of the first, second and third anniversaries of the grant date.
(5)	The deferred share units vest one third over three years beginning on the first anniversary of the grant date.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Karp David 3780 BAYRIDGE AVENUE VANCOUVER, A1 V7V 3J2			Chief Financial Officer

Signatures
/s/ David Karp		9/9/2019
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} Share on Facebook Share on Twitter Share on Email